Clinical Trial Detail

NCT ID NCT02025803
Title A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Taiho Oncology, Inc.
Indications

colorectal cancer

Advanced Solid Tumor

breast cancer

Therapies

Capecitabine + TAS-114

Age Groups: adult

No variant requirements are available.